AQST Net Income
-$78.23MTTM · USD
Period ending:
AQST FY Net IncomeUSD
$0.00-$83.78M
2016-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
AQST net income history
Total earnings after all expenses, taxes, and interest. The available annual fiscal periods series contains 10 observations from Dec 31, 2016 to Dec 31, 2025.
| Period ending | Net Income (USD) |
|---|---|
| -83,784,000 | |
| -44,137,000 | |
| -7,870,000 | |
| -54,410,000 | |
| -70,539,000 | |
| -55,783,000 | |
| -66,246,000 | |
| -61,376,000 | |
| -8,943,000 | |
| -9,602,000 |
Compare net income
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) net income
- Bridgebio Pharma Inc (BBIO) net income
- Brightspring Health Services Inc (BTSG) net income
- Madrigal Pharmaceuticals Inc (MDGL) net income
- Ensign Group Inc (ENSG) net income
- Glaukos Corp (GKOS) net income
- Vaxcyte Inc (PCVX) net income
- Krystal Biotech Inc (KRYS) net income
All AQST financial metrics · AQST stock overview · How to interpret financial metrics
